These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20806120)

  • 21. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
    Greinacher A; Warkentin TE
    Expert Rev Hematol; 2008 Oct; 1(1):75-85. PubMed ID: 21083008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-dependent platelet antibodies in children: problem or merely problematic?
    Parker RI
    Pediatr Crit Care Med; 2007 Jul; 8(4):404-5. PubMed ID: 17622926
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis.
    Kramer R; Oberg-Higgins P; Russo L; Braxton JH
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):439-41. PubMed ID: 19129243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
    Tan Y; Cao L; Lv JC; Yan Y; Zuo L; Wang M; Yu L; Yu F; Zhao MH
    Thromb Haemost; 2009 Dec; 102(6):1282-4. PubMed ID: 19967164
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High ANTI-PF4/Heparin Antibodies Titer and Thromboses Due to Infection 9 Months After Cessation of Heparin in Hemodialyzed Patient With Heparin-Induced Thrombocytopenia.
    Sain M; Burilovic V; Tomicic M; Jelicic I
    Ther Apher Dial; 2018 Oct; 22(5):558-559. PubMed ID: 29856115
    [No Abstract]   [Full Text] [Related]  

  • 27. [Thrombocytopenia can be HIT. Heparin treatment can cause low life-threatening thrombocyte levels].
    Själander A; Johansson L; Hillarp A; Bergqvist D; Tengborn L; Svensson P
    Lakartidningen; 2009 Mar 4-10; 106(10):682-5. PubMed ID: 19418688
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: molecular pathogenesis.
    Visentin GP
    Thromb Haemost; 1999 Aug; 82(2):448-56. PubMed ID: 10605736
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
    Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
    Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-induced thrombocytopenia in the ICU: an overview.
    Sakr Y
    Crit Care; 2011; 15(2):211. PubMed ID: 21457505
    [No Abstract]   [Full Text] [Related]  

  • 33. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
    Shoenfeld Y
    Isr J Med Sci; 1997 Apr; 33(4):243-5. PubMed ID: 9347871
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia: an overview.
    Kelton JG
    Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.